Atrium of ILS2
Image of Emenike Onyido

Dr Emenike Onyido

Research and Development Innovation Officer, Medicine

Telephone number

+44 (0) 1792 513871

Email address

Research Links

Available For Postgraduate Supervision

About

Emenike obtained his BSc. in Biochemistry from Temple University Philadelphia USA, MSc in Drug Discovery & Development from the University of Sunderland and PhD. In Gastroenterology with focus on cancer genetics in colorectal cancer from the University of Nottingham.

He is based within the Reproductive Biology and Gynaecological Oncology (RBGO) and his current research is focused on identifying and evaluating novel Anti-Drug Conjugate (ADC) targets of ovarian cancer through the application of characterization techniques that enable a more robust assessment of the affinity, tumor penetration, and cell internalization properties of ADCs.

Additionally, other clinical research interests are centered around gynecological (ovarian, endometrial) as well as colorectal cancer.

Areas Of Expertise

  • Molecular Biology
  • Biochemistry
  • Drug Discovery
  • Antibody-Drug Conjugate
  • Signal Transduction
  • Biacore™ (SPR) Analysis
  • Cancer Genetics
  • Molecular Biology

Career Highlights

Research

Emenike’s research interests includes Drug Discovery, Signal Transduction, microRNA biology, Cancer Genetics, Molecular Biology, Genetics.

Collaborations

Cluster for Epigenomic and Antibody Drug Conjugates Therapeutics project (CEAT) 2019.